| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-04-02 |
$17.44 |
0.0% |
53,969
|
$941,285 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-03-28 |
$17.50 |
0.0% |
113,384
|
$1,983,824 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-03-25 |
$17.66 |
0.0% |
136,696
|
$2,414,722 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-03-20 |
$17.77 |
0.0% |
201,844
|
$3,586,283 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-03-04 |
$17.24 |
0.0% |
27,953
|
$481,849 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-03-03 |
$16.99 |
0.0% |
663,761
|
$11,275,555 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-02-14 |
$15.25 |
0.0% |
411,430
|
$6,274,767 |
| Broadwood Partners, L.P. |
Non-Executive |
Oncocyte Corp (OCX)
|
2025-02-06 |
$2.05 |
0.0% |
5,165,695
|
$10,589,675 |
| Broadwood Partners, L.P. |
Non-Executive Director |
Lineage Cell Therapeutics, Inc. (LCTX)
|
2025-01-27 |
$0.76 |
0.0% |
7,894,737
|
$6,000,000 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2025-01-16 |
$21.47 |
0.0% |
29,376
|
$630,839 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2024-12-18 |
$24.28 |
0.0% |
80,200
|
$1,947,540 |
| Broadwood Partners, L.P. |
Non-Executive |
Oncocyte Corp (OCX)
|
2024-10-02 |
$2.95 |
0.0% |
1,315,339
|
$3,877,619 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2024-05-09 |
$42.56 |
-26.7% |
1
|
$43 |
| Broadwood Partners, L.P. |
Non-Executive |
Oncocyte Corp (OCX)
|
2024-04-11 |
$2.92 |
4.6% |
2,420,000
|
$7,057,688 |
| Broadwood Partners, L.P. |
Non-Executive Director |
Lineage Cell Therapeutics, Inc. (LCTX)
|
2024-02-06 |
$1.04 |
-16.2% |
6,730,770
|
$7,000,001 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2024-01-08 |
$27.11 |
15.1% |
4,042
|
$109,570 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2024-01-05 |
$28.61 |
9.1% |
226,553
|
$6,481,557 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-11-30 |
$31.50 |
-1.0% |
434,991
|
$13,703,831 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-11-13 |
$32.74 |
-4.7% |
34,827
|
$1,140,132 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-11-09 |
$33.42 |
-6.6% |
289,140
|
$9,662,782 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-11-06 |
$34.93 |
-10.7% |
309,154
|
$10,797,514 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-10-06 |
$37.81 |
-17.5% |
205,296
|
$7,762,466 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-09-21 |
$40.12 |
-22.2% |
291,383
|
$11,689,354 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2023-09-07 |
$41.42 |
-24.7% |
189,962
|
$7,868,913 |
| Broadwood Partners, L.P. |
Non-Executive |
Oncocyte Corp (OCX)
|
2023-04-03 |
$6.03 |
-49.5% |
1,341,382
|
$8,093,898 |
| Broadwood Partners, L.P. |
Non-Executive |
STAAR SURGICAL CO (STAA)
|
2022-12-29 |
$47.42 |
-34.2% |
191,075
|
$9,061,575 |
| Broadwood Partners, L.P. |
Non-Executive |
Oncocyte Corp (OCX)
|
2022-04-14 |
$26.65 |
-88.6% |
300,188
|
$8,000,000 |
| Broadwood Partners, L.P. |
Non-Executive Director |
Lineage Cell Therapeutics, Inc. (LCTX)
|
2022-03-25 |
$1.42 |
-38.5% |
930,106
|
$1,317,667 |
| Broadwood Partners, L.P. |
Non-Executive |
OncoCyte Corp (OCX)
|
2021-02-05 |
$90.00 |
-96.6% |
30,000
|
$2,700,000 |
| Broadwood Partners, L.P. |
Non-Executive |
OncoCyte Corp (OCX)
|
2021-01-20 |
$68.48 |
-95.5% |
73,014
|
$4,999,999 |
| Broadwood Partners, L.P. |
Non-Executive |
OncoCyte Corp (OCX)
|
2020-04-24 |
$45.40 |
-93.3% |
52,500
|
$2,383,500 |
| Broadwood Partners, L.P. |
Non-Executive |
OncoCyte Corp (OCX)
|
2020-01-02 |
$43.12 |
-92.9% |
69,573
|
$3,000,001 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-20.4% |
$-35,179,131 |
$172,834,446 |